Your browser doesn't support javascript.
loading
Recurrent Omental Hemangiopericytoma: A Therapeutic Challenge.
Jaber, Sara; Winer, Ira; Rasool, Nabila.
Afiliação
  • Jaber S; Division of Gynecologic Oncology, Department of Women's Health Services, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Winer I; Department of Oncology, Division of Gynecologic Oncology, Wayne State University, Karmanos Cancer Center, 4160 John R., Suite 721, Detroit, MI 48201, USA.
  • Rasool N; Division of Gynecologic Oncology, Department of Women's Health Services, Henry Ford Hospital, Detroit, MI 48202, USA.
Case Rep Obstet Gynecol ; 2016: 2075157, 2016.
Article em En | MEDLINE | ID: mdl-27088021
Hemangiopericytomas are vascular tumors with a susceptibility to arise anywhere in the human body. We present a case of a 68-year-old female with primary omental hemangiopericytoma and a two-time recurrence managed with surgery and close follow-up. The first recurrence was at 52 months and the second at 37 months following the prior presentation. No adjuvant chemotherapy or radiation therapy was administered. Given the widespread nature of the cell of origin, routine follow-up postoperatively with interval imaging in order to detect recurrences is imperative. Pathologic tumor characteristics may determine potential for recurrence and may also assist in determining whether adjuvant treatment modalities should be included in the management plan. Review of the English literature reveals a total of 24 cases of omental hemangiopericytomas inclusive of the current report.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article